Dr. Kimihiko Oishi, M.D., is the Chair and Professor of the Department of Pediatrics at the Jikei University School of Medicine in Tokyo, Japan, and Vice President of the Japanese Society for Inherited Metabolic Diseases. He also serves as Vice President of the Japanese Society for Neonatal Screening and is actively engaged in improving Japan’s newborn screening system through clinical research, policy collaboration, and international partnerships.
Dr. Oishi was trained in Molecular Developmental Biology, Pediatrics, and Medical Genetics at the Icahn School of Medicine at Mount Sinai in New York, USA. After completing his clinical training, he joined the faculty at Mount Sinai as an Attending Physician for the Program for Inherited Metabolic Diseases Clinic, with a particular interest in disease mechanisms and the development of new therapies for inborn errors of metabolism (IEM).
Since returning to Tokyo in 2021, Dr. Oishi has continued his clinical and basic research on IEM in Japan. He received his M.D. from the Jikei University School of Medicine and holds board certifications in Pediatrics and Medical Genetics in both the United States and Japan.
Dr. Kimihiko Oishi, M.D., is the Chair and Professor of the Department of Pediatrics at the Jikei University School of Medicine in Tokyo, Japan, and Vice President of the Japanese Society for Inherited Metabolic Diseases. He also serves as Vice President of the Japanese Society for Neonatal Screening and is actively engaged in improving Japan’s newborn screening system through clinical research, policy collaboration, and international partnerships.
Dr. Oishi was trained in Molecular Developmental Biology, Pediatrics, and Medical Genetics at the Icahn School of Medicine at Mount Sinai in New York, USA. After completing his clinical training, he joined the faculty at Mount Sinai as an Attending Physician for the Program for Inherited Metabolic Diseases Clinic, with a particular interest in disease mechanisms and the development of new therapies for inborn errors of metabolism (IEM).
Since returning to Tokyo in 2021, Dr. Oishi has continued his clinical and basic research on IEM in Japan. He received his M.D. from the Jikei University School of Medicine and holds board certifications in Pediatrics and Medical Genetics in both the United States and Japan.